🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to share The Mayo Clinic Guide to Better Sleep! Dr. Kolla, I, & collegues wrote this to bring you practical, science-backed advice to conquer insomnia and other sleep probs. Helping you achieve better sleep—and better health—is our passion.🌙🛏️ MayoPCCM Mayo Clinic

IT IS OUT!... Take a look at my book!! link.springer.com/book/10.1007/9… Thanks to all the experts from around the world who contributed to this outstanding work #aspergillosis #aspergillus #pulmonary ACCP American Thoracic Society (ATS) ERS publications IDSA SCCM ESICM Wayne State University School of Medicine Wayne State University

🚨 Excited to share our latest work to start off 2025! Our chapter "Invasive Pulmonary Aspergillosis in Other Patient Populations" is now published! 🦠📚 A closer look at this challenging condition in diverse patient groups. Read more here: link.springer.com/chapter/10.100…

Perspectives of Clinicians on the Value of the Get to Know Me Board in... sciencedirect.com/science/articl… by Sumera Ahmad & Luda Karnatovskaia

Dr. Patel taking the Chest team to see the helipad and meet the Mayo One team. MayoPCCM our fellows are sub-attending in our inpatient Pulm service, where we care for several Pulm pathologies. Including pts who need to be 🚁🚁🚁 airlifted to Mayo #meded #pccm #whymayopccm

♨️♨️♨️ Hot of the press: Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis | New England Journal of Medicine nejm.org/doi/full/10.10…

Come learn to study the lung microbiome at ATS 2025! Meet and learn from an all-star team of experts. San Francisco, May 16th.

🔥🔥🔥 Hot of the press: Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older: results from two randomised, active-controlled, phase 3 trials buff.ly/leEyerJ #cysticfibrosis

🔥 🔥 🔥 Hot of the press: Cardiovascular benefits and safety profile of macrolide maintenance therapy in patients with bronchiectasis buff.ly/CGXv34s

Asthma outcomes in a safety net hospital system: A comparative study t... sciencedirect.com/science/articl… BCM PCCSM section BCM Clinician Resources The Lung Institute at Baylor Medicine

European #Bronchiectasis Patient Conference suggestion: bring the checklist to your doctor!!! Am I getting ALL of these recommendations??

🔥 🔥 🔥 Our ATS PI-TB Assembly Winter Highlights Newsletter is now available online! Find out about the newest ATS Workshop on TB, read about upcoming Webinar on #WorldTBDay2025 and find out what our Early Career Stars are doing! buff.ly/95IreCx @ATScommunity ATS_Assemblies

Proud and humbled to share that our abstract received the PAR Abstract Award at the ATS 2025 conference🎉 Huge thanks to my mentor Amjad Kanj and MayoPCCM for the tremendous support. Excited to present, connect, and learn from the #ATS2025 community! See you in San Francisco🌉

You can’t win (while learning) if you don’t play! And the free trips to #chest2025, the $9,000 in cash, and other prizes* are NOT even the best part, by far! Gameplay ends 30th April online CHEST *dozens of free registrations, on demand board review courses, SEEK books…

2022 Zhenmei Zhang

Congratulations to PITB Abstract Awardees!!!#ATS2025

Thrilled to have presented our work at #ATS2025—an incredible experience full of learning, collaboration, and inspiration from the American Thoracic Society (ATS). Deep appreciation to my mentor Amjad Kanj and MayoPCCM for their incredible guidance and support.

Honored to present our award-winning abstract “Fungi in the Airways: Association with Bacterial and Mycobacterial Co-isolation in Bronchiectasis” at #ATS2025! Thanks to the PCD Foundation for the recognition, and to Amjad Kanj, Dr. Sarah Chalmers, and MayoPCCM for their support!

🚨 New clinical review on bronchiectasis & inflammation! We outline the landscape: neutrophilic, eosinophilic, immune dysregulation, and more. Grateful for Amjad Kanj's mentorship. "Bronchiectasis: A clinical review of inflammation" 👉 authors.elsevier.com/c/1lABA3P3Qv0I… #MedTwitter #PCCM

A successful investigator initiated randomized clinical trial is not as easy as it sounds. Many years of work, many barriers to overcome. Time: Idea to Approval: 1-2 years Approval to Opening: 1 year Opening to Accrual: 3-5 years Accrual to Result: 2-5 years Result to